For the Inventor, By the Inventor

Enter assignee name

New Delhi, India

Fresenius Kabi Oncology Limited

USPTO Granted Patents = 31

EPO Patents = 19

Forward Citations = 68

Loading Chart...

Loading Chart...

78 inventors (with patents filed for the assignee):

Saswata Lahiri (19 out of 22 patents)

Walter Cabri (11 out of 71 patents)

Bhuwan Bhaskar Mishra (8 out of 8 patents)

4. Dhiraj Khattar (8 out of 13 patents)

5. Nilendu Panda (7 out of 7 patents)

6. Nitin Kumar Gupta (7 out of 170 patents)

7. Abul Azim (6 out of 6 patents)

8. Govind Singh (6 out of 9 patents)

9. Rajesh Khanna (6 out of 6 patents)

10. Vinod Singh Tomar (4 out of 4 patents)

11. Sarbjot Singh Sokhi (4 out of 4 patents)

12. Maneesh Kumar Pandey (4 out of 4 patents)

13. Raj Narayan Tiwari (4 out of 4 patents)

14. Sunil Sanghani (4 out of 4 patents)

15. Nikunj Shambhubhai Kachhadia (4 out of 4 patents)

31 patents: Sort by Forward Citations

1. 11883403 - Pharmaceutical compositions comprising Afatinib (2024-01-30),

2. 11739057 - Polymorphic forms of Belinostat and processes for preparation thereof (2023-08-29),

3. 11667654 - Process for the preparation of boronic acid esters (2023-06-06),

4. 11465999 - Process for preparing Alectinib or a pharmaceutically acceptable salt thereof (2022-10-11),

5. 11440912 - Process for the preparation of ribociclib and its salts (2022-09-13),

6. 11390612 - Polymorphic forms of Afatinib free base and Afatinib dimaleate (2022-07-19),

7. 11098037 - Process for preparing alectinib or a pharmaceutically acceptable salt thereof (2021-08-24),

8. 11078231 - Process for purification of carfilzomib intermediate (2021-08-03),

9. 11059777 - Polymorphic forms of belinostat and processes for preparation thereof (2021-07-13),

10. 10800763 - Polymorphic forms of Afatinib free base and Afatinib dimaleate (2020-10-13),

11. 10544109 - Process for the preparation of xylene linked cyclam compounds (2020-01-28),

12. 10525059 - Pharmaceutical compositions comprising Afatinib (2020-01-07),

13. 10253066 - Process for purification of Carfilzomib (2019-04-09),

14. 9968608 - Pharmaceutical compositions comprising pemetrexed and tromethamine (2018-05-15),

15. 9872873 - Process for preparing stable pharmaceutical compositions of compounds susceptible to hydrolysis (2018-01-23),

Fresenius Kabi Oncology Limited is a leading global healthcare company specializing in the field of oncology. They develop and manufacture innovative pharmaceutical products for the treatment of various types of cancer. With a commitment to improving patients' lives, they strive to provide high-quality and affordable cancer therapies. For more information, visit their website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

31 Patents

#7 in New Delhi

#61 in India

#20,624 in the World

New Delhi, India

Fresenius Kabi Oncology Limited

Forward Citations = 68

78 inventors:

Saswata Lahiri (19 out of 22 patents)

Walter Cabri (11 out of 71 patents)

Bhuwan Bhaskar Mishra (8 out of 8 patents)

4. Dhiraj Khattar (8 out of 13 patents)

5. Nilendu Panda (7 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…